[MO4] Mini-Oral Session 4　Lung Cancer / Thoracic Cancer 2（Miscellaneous）
【E】

[MO4-2] Pharmacokinetic and dose finding study of osimertinib in patients with impaired renal function and low body weight

^○Takae Okuno¹, Yutaka Fujiwara^2,3, Makihara Reiko⁴, Hase Tetusnari⁵, Hashimoto Naozumi⁵, Kobayashi Misato¹, Naito Tomoyuki³, Takahashi Toshiaki⁶, Kobayashi Haruki⁶, Shinnno Yuki⁷, Ikeda Takaya^8,12, Goto Koichi⁸, Hosomi Yukio⁹, Watanabe Kageaki⁹, Kitazono Satoru¹⁰, Sakiyama Naomi⁴, Makino Yoshinori¹¹, Yamamoto Noboru⁷ (1.Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine, 2.Department of Thoracic Oncology, Aichi Cancer Center, 3.Department of Respiratory Medicine, Mitsui Memorial Hospital, 4.Department of Pharmacy, National Cancer Center Hospital, 5.Department of Respiratory Medicine, Graduate School of Medicine, Nagoya University, 6.Division of Thoracic Oncology, Shizuoka Cancer Center, 7.Department of Thoracic Oncology, National Cancer Center Hospital, 8.Department of Thoracic Oncology, National Cancer Center Hospital East, 9.Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 10.Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 11.Department of Pharmacy, Department of Cancer Genome Medicine, Saitama Medical University International Medical Center., 12.Department of Respiratory Medicine, Nagasaki Kita Tokushukai Hospital)